Michelson Diagnostics has released a preliminary specification for its clinical Optical Coherence Tomography (OCT) probe and processing system, which the company says is planned for launch in late spring 2009.
The new OCT system has been given the name 'Vivosight'. Two variants of the new Vivosight probe are specified, one is a version with X-Y scanning, to enable 3D mapping of flat tissue such as skin, and the other is a version equipped with a rigid endoscope, suitable for internal applications.
The unique multi-beam design provides double the image resolution (i.e. better than 10μm) available from conventional single-beam designs, resulting in crisper, clearer OCT images, showing more clinical detail.